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Abstract
The role of the central nervous system in the modulation and precipitation of sudden cardiac
death has been a matter of controversy for decades. Establishing a cause-effect relationship in
the setting of a cerebro-vascular event has been complex, as patients with stroke usually have
risk factors for coronary artery disease as well. This article will review both experimental and
clinical evidence relating to the mechanisms that link the central nervous system and the
cardiovascular system. Cardiovascular consequences of stroke and epilepsy will be also re-
viewed. (Cardiol J 2009; 16, 2: 105–112)
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Introduction
The role of the central nervous system (CNS)
in the modulation and precipitation of sudden car-
diac death has been a matter of controversy for de-
cades. Initial observations in patients with acute
stroke reported by Norris [1] documented the pre-
sence of marked electrocardiogram (ECG) changes
and cardiac arrhythmias in 50% of patients with an
acute stroke. Establishing a cause-effect relation-
ship in this setting has been complex as patients
with stroke usually have risk factors for coronary
artery disease as well. Nonetheless, some studies
have documented a significant increase in ECG al-
terations, characterized by ST-segment and QT in-
terval alterations, as well as a higher incidence of
ventricular arrhythmias, including ventricular fibril-
lation in patients with acute stroke [2, 3]. This ar-
ticle will review both experimental and clinical evi-
dence relating to the mechanisms that link the cen-
tral nervous system and the cardiovascular system.
Cardiovascular consequences of stroke and epilep-
sy will be reviewed as well.
The limbic system
Much experimental evidence indicates that the
final common pathway for most cardiac arrhythmias
induced by central neural stimulation is related to the
limbic system, specifically the amygdala and insular
regions [4]. Stimulation of these areas induces mar-
ked sympathetic activation that is persistent even
after vagal stimulation or vagal section [4]. Acute stro-
ke, both experimentally and clinically, has been do-
cumented to induce focal myocytolysis in a series of
patients with acute stroke that died suddenly due to
ventricular fibrillation [5]. Focal myocytolysis is preci-
pitated by increased sympathetic activation, which in
turn increases ventricular vulnerability [5]. Central in-
tegration of the autonomic nervous system by the lim-
bic system and insula plays an important role in modu-
lating cerebrogenic sudden cardiac death (Fig. 1).
The role of the insula
Sudden cardiac death often occurs in individu-
als with increased coronary risk factors including
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hypertension, hypercholesterolemia, smoking, and
stress; factors that are causally associated with co-
ronary atherosclerosis and acute coronary syndro-
mes. In many cases, sudden death results from
a fatal arrhythmia during the acute coronary event,
or is related to the resultant abnormal anatomic
substrate (i.e. ischemic cardiomyopathy). However,
some postmortem examinations of sudden death
victims fail to identify either coronary or myocar-
dial pathology [6]
As with coronary heart disease, there is a well-
established association between sudden death and
certain neurologic conditions. Moreover, both neu-
rologic pathology and alterations of emotional sta-
tes can produce autonomic imbalance resulting, at
their most serious, in cerebrogenic sudden death
[4, 7]. Indeed, there are a number of neurologic di-
sorders that produce ECG alterations which may be
predictive of sudden death, such as QT interval pro-
longation, late ventricular potentials, premature
ventricular beats, non-sustained ventricular tachy-
cardia (VT), and the R on T phenomenon. These in-
clude subarachnoid hemorrhage, intracerebral he-
morrhage and ischemic stroke (Figs. 1, 2). Although
less frequent, the same ECG changes can be found
in patients with cerebral tumours, meningitis, mul-
tiple sclerosis, and spinal cord lesions (Table 1).
The cardio-specific isoenzyme creatine kina-
se increases with cerebrogenic ECG changes, but
its concentration-time curve differs from that seen
in acute coronary syndromes. Specifically, creati-
ne kinase remains elevated during the four days
after stroke, whereas it begins to fall within hours
of an acute coronary syndrome [8].
Postmortem analyses of patients who died sud-
denly and without evidence of coronary artery di-
sease frequently demonstrate myocytolysis and
myofibrillar degeneration [5]. Such changes have
also been observed in experimental models of he-
arts subjected to sympathetic overstimulation.
Many have proposed a link between central nervo-
us system pathology and the development of fatal
arrhythmias involving the autonomic nervous sys-
tem, specifically increases in sympathetic tone [9].
Cardiovascular conditions related to sympathetic
nervous system pathology are classified as:
— central: cerebrogenic pulmonary oedema: in-
crease in pulmonary intravascular pressure
(the common final pathway is an increase in
sympathetic tone due to an increase in intra-
cranial pressure, i.e.: subarachnoid hemorrha-
ge, focal lesions, etc);
— peripheral: increased sympathetic nervous di-
scharge: increased secretion of adreno-medul-
lary catecholamines, reduced parasympathetic
activity. The imbalance of the autonomic ne-
rvous system over the electrical cardiac struc-
tures is the basis of the supraventricular and
ventricular arrhythmias observed during cere-
brogenic diseases.
Figure 1. Brain-heart anatomical interactions. Integration of physiological responses.
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Figure 2. A. 12-lead ECG of a 64-year-old woman with no significant past medical history who collapsed in the lobby
of her apartment building. The CT-scan demonstrated a right subdural hematoma with intracerebral right temporal
and insular hemorrhage. The angiogram demonstrated normal epicardial coronary arteries. The 2-D echocardio-
gram was unremarkable. Note normal sinus rhythm with a dramatically prolonged QTc interval of 840 ms; B. 12-lead
ECG of the same patient within 24 hours of admission. The ECG shows torsades de pointes in the setting of QTc
interval prolongation; C. 12-lead ECG of the same patient 72 hours post-stroke. The ECG shows normal sinus rhythm
with no ST changes or QTc prolongation (450 ms).
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There is a viscerotropic sensory representa-
tion in the insula. Afferent pathways arise from the
taste buds, the gastrointestinal tract, the respira-
tory tract, and both baroreceptors and chemorecep-
tors in the heart. Efferent pathways include connec-
tions with the parabrachial nucleus, the contralate-
ral insula, cortical regions, the thalamus, lateral
hypothalamic areas, and the amygdala. The insula
also has specific areas controlling vasopressor and
vasodepressor responses [10, 11]. Experimental sti-
mulation of the insula produces changes in arterial
pressure and heart rate. Specifically, sites produ-
cing tachycardia are located in the rostral posterior
insula; with bradycardia-producing sites located in
the caudal posterior insula [11]. There is an impor-
tant connection between the insula and the amyg-
dala, where the central cardiovascular control wi-
thin the limbic system is located. The amygdala
regulates the changes over the heart during stress
stimulation by liberation of neuropeptid Y and neu-
rotensin [9, 10].
Heart rate variability (HRV) is an indirect me-
thod to assess cardiac sympathetic and parasympa-
thetic interplay. Following acute stroke, vagal tone
is reduced and the circadian variation of HRV is
abolished. These changes have been implicated in
the development of fatal arrhythmias and sudden
death [7, 11].
Moreover, when acute stroke affects the insu-
la, associations with higher serum epinephrine le-
vels, higher blood pressure, and longer QT intervals
can be observed [9–11].
In a retrospective analysis of 179 patients,
Christensen et al. [12] analyzed 43 patients with in-
sular lesions.  Insular lesions were significantly as-
sociated with higher sinus rate (p = 0.001), ectopic
beats (p = 0.032), and ST-segment elevation (p =
= 0.011). Additionally, right-sided insular lesions
were related to atrial fibrillation (p = 0.009) and
atrio-ventricular (AV) block (0.029).
It is clear that the insula plays an important role
in the interaction between the central nervous sys-
tem and the autonomic nervous system. Intracra-
nial lesions affecting the insula may trigger an au-
tonomic imbalance that increases ventricular vul-
nerability and the risk of sudden death.
Lateralization of control
There is evidence to support lateralization,
which is a differential effect from each cerebral he-
misphere, in neurocardiac control [13]. Heart rate
increases with left hemispheric inactivation and de-
creases with right hemispheric inactivation. Expe-
rimentally, the right cerebral hemisphere has been
shown to modulate sympathetic activity [13]. Cli-
nically, this correlates with increased arrhythmias
and arrhythmic death following acute right-hemi-
spheric stroke. Moreover, right-sided lesions not
only increase sympathetic tone, but also decrease
parasympathetic tone [13]. Conversely, the risk of
sudden death was increased following left-sided
cerebral infarcts (HR 1.40; CI 95% 1.00–2.00) over
a 5 year follow-up period in the North American Symp-
tomatic Carotid Endarterectomy Trial (NASCET)
[14]. One possible explanation for these conflicting
findings is that patients suffering right-sided infarcts
may have died during the acute stroke. Alternati-
vely, selection bias resulting from overrepresenta-
tion of patients with left-sided carotid disease in the
trial may explain this conflict [14].
Tokgözoglu et al. [11] demonstrated a more
profound decrease in HRV (p < 0.001) when the ri-
ght middle cerebral artery and insula were affected
in a cohort of 62 patients with acute ischemic stro-
ke [11]. Correspondingly, there was a higher inci-
dence of sudden death in patients experiencing ri-
ght-sided strokes.
Inter-hemispheric connectivity between the two
insulae provides an integrated patterning of cardio-
vascular regulation to diencephalic and brainstem
autonomic centres. Zhang and Oppenheimer [15]
experimentally demonstrated reciprocal insulo-insu-
lar connectivity by stimulation of the contralateral
Table 1. Electrocardiographic changes during
central nervous system lesions.
1. Morphology changes




e. J waves (Osborne)
f. QTc interval prolongation




c. High degree AV block (suprahisian block)
3. Tachyarrhythmias
a. Supraventricular tachyarrhythmias: AF
b. Ventricular tachyarrhythmias: frequent pre-
mature ventricular contractions, non-sustained
VT, sustained VT, ventricular fibrillation,
polymorphic VT, or torsades des pointes
as sociated with QTc interval prolongation
AV – atrioventricular, AF — atrial fibrillation, VT — ventricular
tachycardia, QTc — corrected QT
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insula using L-glutamate. This study suggests that
communication between the two insulae is required
for balanced interhemispheric cardiovascular control.
The level of the heart-brain link
There is evidence that precipitating triggers for
sudden death are present in the central nervous
system: circadian rhythms, plasmatic cortisol fluc-
tuations, variations in sympathetic traffic, decreases
in melatonin levels, increases in plasma serotonin,
and cholinergic withdrawal. Furthermore, these
triggers may interact on several different levels [9].
Suprachiasmatic nucleus,
pineal gland, and pituitary
The circadian rhythm of sunlight and darkness
are mediated through afferent pathways travelling
via the retino-hypothalamic tract. Additionally, con-
nections from the suprachiasmatic nucleus to the
pineal gland stimulate the secretion of neurotran-
smitters following this circadian rhythm. Alteration
in the daylight-darkness sequence as it relates to
physical activity or inactivity may result in altera-
tions of neurotransmitter secretion, resulting in po-
tential triggers for cardiovascular diseases [16].
Higher centres
A number of exogenous stress triggers, inclu-
ding sleep deprivation and extremes of emotion, sti-
mulate specific areas in the higher nervous centres.
There is some evidence that variations in melato-
nin levels related to stimulation of these centres can
trigger ventricular arrhythmias and affect ventricu-
lar vulnerability [16].
Sympathetic neural activity
An increase in cardiac vulnerability is observed
with stimulation of the stellate ganglion. Stimula-
tion of the left stellate ganglion predominantly af-
fects the posterior surface of the heart, whereas
stimulation of the right affects the anterior wall.
Associated increases in sympathetic output follo-
wing stimulation of the stellate ganglia decrease
HRV by increasing sympathetic tone as well as the
ventricular fibrillation threshold [17]. Similarly,
during the acute phase of a myocardial infarction,
abrupt increases in sympathetic tone can precipi-
tate primary ventricular fibrillation even in the ab-
sence of structural heart disease.
Psychological factors
Psychological stress has objective validation by
its repercussions throughout the autonomic nervous
system. Elevations in sympathetic output increase
myocardial vulnerability and, subsequently, suscep-
tibility to ventricular arrhythmias [18]. Experimen-
tally, stressful environments increase mean heart
rate and the number of ventricular premature con-
tractions. However, despite these well-documen-
ted effects on heart rate and rhythm, the neural pa-
thways that integrate these circuits remain contro-
versial.
There are several well-recognized psychologi-
cal triggers of ventricular arrhythmias, including
academic examinations, public speaking, and dri-
ving. Indeed, there is a strong correlation between
job loss or loss of a spouse/loved one and an incre-
ase in sudden cardiac death [18]. Such triggers can
be reduced by increasing vagal tone or through ad-
renergic blockade.
In the last few years a new clinical entity, va-
riably called Takotsubo cardiomyopathy, transient
left ventricular apical ballooning, and “broken he-
art” syndrome, has gained widespread recognition
in the cardiovascular literature. The condition is ty-
pically characterized by transient myocardial dys-
function (ventricular mid-apical akinesis, or “ballo-
oning”) with ST-segment elevation in the anterior
precordial leads followed by T-wave inversion much
resembling an evolving acute anterior myocardial
infarction. The epicardial arteries are usually free
of significant atherosclerosis and any associated de-
pression in left ventricular function recovers in days
to weeks [19]. Both psychological and physical
stressors are recognized as precipitants of this con-
dition, and excessive catecholamine levels have
been implicated as the putative mechanism. Despite
a typically benign course, rare cases of associated
corrected QT (QTc) interval prolongation, torsades
des pointes, and conduction defects have been re-
ported [20]. The electrocardiographic manifesta-
tions and transient wall motion abnormalities seen
in Takotsubo syndrome are almost indistinguisha-
ble from those observed during intracranial lesions.
Triggering ventricular arrhythmias
Experimental evidence from microstimulation
of the insula underscores the brain-heart connec-
tion as it pertains to arrhythmogenesis. Such expe-
riments have demonstrated that stimulation of spe-
cific areas of the insula can precipitate arrhythmo-
genic triggers, including frequent ventricular
depolarisations, high degree AV block, and the R
on T phenomenon [11]. Such changes correlate with
elevated norepinephrine levels and myocytolysis
[5]. Furthermore, central nervous system damage
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involving the insula can trigger overstimulation of
the amygdala, resulting in liberation of neuroche-
mical mediators synergistic with sympathetic sti-
mulation [8].
The risk of sudden death
in the post-stroke period
The initial stroke is the main cause of death in
the first month following acute ischemic stroke.
After the first year, however, non-stroke cardiova-
scular disease is the most common cause of death
in these patients. There is no consensus about how
to evaluate the post-stroke patient in order to iden-
tify a subgroup at high risk for sudden death. Fre-
quently, these patients are limited in their ability
to perform exercise tests and invasive tests should
not be routinely used as screening methods.
Prolongation of the QTc interval is related to
an increase in cardiovascular events [21]. Clinical
observations have identified that patients with
ischemic stroke, hemorrhagic stroke, or subarach-
noid hemorrhage are prone to QTc interval prolon-
gation (Figs. 2A–C). Wong et al. [21] retrospecti-
vely analyzed 404 stroke survivors with respect to
QTc prolongation. Prolongation of the QTc interval
in lead V6 ≥ 480 ms was found to be a strong pre-
dictor of cardiovascular death during the follow-up
period (RR 2.9; 95% CI 1.6–5.3; p < 0.001). Such
prolongation was associated with a 3-fold increase
in the risk of cardiac death and 2.5-fold increase in
the risk of death from any cause [21]. Kono et al.
[22] demonstrated that patients who developed ST
elevation during acute subarachnoid hemorrhage
had reduced cardiac contractility despite identifica-
tion of normal coronary arteries on angiography.
Despite these observations, it is unclear whe-
ther patients in the post-stroke period are more su-
sceptible to sudden cardiac death related to brain-
heart dysfunction, or whether sudden cardiac de-
ath is a manifestation of the overlapping risk factors
for ischemic stroke and coronary artery disease.
The answer may lie in the young patient with sub-
arachnoid hemorrhage, a demographic in which pre-
existing coronary artery disease is extremely rare.
In this population, electrocardiographic abnormali-
ties are still present, suggesting a direct associa-
tion between brain injury and cardiac outcome. In
a recent review of ECG abnormalities and QT inte-
rval prolongation accompanying acute stroke, Khe-
chinashvili et al. [23] found a high prevalence of
ECG changes in the acute phase of subarachnoid
hemorrhage (76%; 95% CI 73–90), intracerebral
hemorrhage (96%), and ischemic stroke (91%;
95% CI 85–95). Furthermore, the frequency of such
ECG changes remained significantly increased in
the absence of structural heart disease.
Increased QT dispersion (QTd) is a marker of
inhomogeneous cardiac repolarization. Such disor-
dered repolarization has been proposed as a risk fac-
tor for sudden death in the setting of various car-
diac diseases [24]. Afsar et al. [25] demonstrated
increased QTd in the first 24 hours post-stroke in
patients without evidence of previous structural
heart disease. In this cohort, there were no signifi-
cant differences according to the localization or type
of stroke [25]. Interestingly, the size of stroke was
statistically significant for QTd prolongation (p <
< 0.05), the QTd increases reverted at 72 hours,
and no differences were found between patients
with and without stroke [25].
Sudden unexpected death
in epilepsy patients
Sudden unexpected death in epilepsy patients
(SUDEP) is a common and devastating cause of de-
ath among patients with epilepsy [26]. The estima-
ted incidence of SUDEP ranges from 0.7 to 1.3 per
1000 patients-years depending on the cohort stu-
died, and from 3.5 to 4.1 per 1000 patients-years
among patients included in anticonvulsant trials and/
or surgery programs [26–28]. Overall, this amounts
to a 24-fold increase in sudden death in patients with
epilepsy compared with matched controls. Identi-
fied risk factors for SUDEP include generalized
tonic-clonic seizures, structural cerebral lesions,
sub-therapeutic plasma anticonvulsant levels, incre-
asing number of anticonvulsants, cognitive delay/
mental retardation, early onset of seizures, prone
position, hyponatremia, and possibly male gender
[26, 27]. More recently identified factors include
early onset of epilepsy, duration of epilepsy, uncon-
trolled seizures, seizure frequency, and winter tem-
peratures [27].
Although much remains to be learned about the
pathophysiology of SUDEP, animal experiments
have implicated postictal central apnea, prone po-
sition, and neurogenic pulmonary oedema as sub-
strates for life-threatening ventricular arrhythmias
[28, 29]. The addition of more than one anticonvul-
sant and/or psychotropic medications could cause
excessive sedation and have a synergic effect du-
ring the postictal period. Prone position during
a seizure could also result in hypoventilation during
the postictal period, further predisposing to ventri-
cular arrhythmia. Finally, autonomic nervous sys-
tem alterations are well described during temporal
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lobe epilepsy. Ictal discharges produce an increase
in efferent sympathetic output, which in turn can
be proarrhythmic and result in QTc prolongation
that could lead to ventricular tachyarrhythmias [30].
Management of brain-heart dysfunction
The cornerstone of management of dysfunctio-
nal brain-heart interaction is prevention of the con-
sequences of cardiac autonomic imbalance [31].
Both the post-stroke and post-myocardial infarction
stages are characterized by increased sympathetic
tone and decreased vagal tone. As described, both
changes result in an increased risk of sudden de-
ath. Possible therapeutic strategies include both
prevention of brain-heart dysfunction, and preven-
tion of sudden death in the context of central ne-
rvous system damage and treatment of cardiovascu-
lar complications.
Prevention of brain-heart dysfunction
It is unclear whether lifestyle changes can con-
tribute to prevention of brain-heart dysfunction.  It
makes sense to reduce stress triggers and to reor-
ganize the circadian rhythms (day/night, total sle-
eping time, etc.). Christensen et al. [32] demonstra-
ted an improvement in vagal tone in patients post
myocardial infarction who were treated with n-3 fat-
ty acids. Similarly, Singh et al. [33] demonstrated
a reduction in cardiac events and beneficial modu-
lation of the circadian rhythms after an acute my-
ocardial infarction with fish oil consumption.
Use of drugs that modulate the renin-angioten-
sin-aldosterone axis, including beta-blockers, angio-
tensin converting enzyme inhibitors, angiotensin
receptor blockers, and aldosterone antagonists, may
contribute to prevention of sudden death through an
as yet unidentified interaction at the autonomic ne-
rvous system level. Further study is needed to de-
termine whether these drugs reduce neurotransmit-
ter plasma concentrations or brain excitation [34].
Temporal lobe epilepsy surgery demonstrated
a reduction in the imbalance of the autonomic ne-
rvous system and its repercussions in the cardio-
vascular system [29]. Further studies are needed
to confirm this observation.
Prevention of sudden death in the context
of central nervous system damage and
treatment of cardiovascular complications
There is no consensus on how best to identi-
fy high-risk patients for prophylactic treatment of
sudden death related to brain-heart dysfunction.
However, cardiovascular dysfunction in the setting
of stroke or subarachnoid hemorrhage should be
aggressively treated [31]. Neurogenic pulmonary
oedema should be treated with diuretics, vasodi-
lators, angiotensin converting enzyme inhibitors,
and inotropes [31]. Evaluation of transient myocar-
dial dysfunction is essential to recognize tempo-
rary stunned myocardium. The use of beta-bloc-
kers is usually beneficial in high blood pressure
control and the reduction of parietal stress. Use
of antiarrhythmic drugs that prolong the QTc in-
terval (amiodarone, Class I, sotalol) should be avo-
ided. Torsades des pointes, a dramatic complica-
tion associated with QTc prolongation during the
acute phase of a stroke or intracranial hemorrha-
ge, should be treated with temporary pacing or iso-
proterenol to increase heart rate and shorten the
prolonged QTc interval.
The rationale for all these therapeutic options
is to prevent sudden death in survivors of an acute
cerebral event (ischemic stroke or cerebral ble-
eding). Most of these interventions are extrapola-
tions of sudden death prevention in different clini-
cal scenarios.
Conclusions
The links between the central nervous system
and autonomic nervous system are anatomically and
physiologically relevant to understand the high pre-
valence of cardiovascular events during the acute and
post-acute period of cerebral events. Physicians in-
volved in the prevention and treatment of sudden
cardiac death should be familiar with the mechani-
sms of brain-heart dysfunction. Special attention
should be given to patients with intracranial bleeding
or ischemic stroke affecting the insula, as well as to
patients with epilepsy at a high risk for SUDEP.
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